Cargando…

Effectiveness of activated carbon masks in preventing anticancer drug inhalation

BACKGROUND: The exposure of healthcare workers to anticancer drugs such as cyclophosphamide (CPA) is a serious health concern. Anticancer drug pollution may spread outside biological safety cabinets even when a closed system is used. The inhalation of vaporized anticancer drugs is thought to be the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Junya, Kogure, Atushi, Kudo, Kenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094061/
https://www.ncbi.nlm.nih.gov/pubmed/27826453
http://dx.doi.org/10.1186/s40780-016-0062-7
_version_ 1782465051603501056
author Sato, Junya
Kogure, Atushi
Kudo, Kenzo
author_facet Sato, Junya
Kogure, Atushi
Kudo, Kenzo
author_sort Sato, Junya
collection PubMed
description BACKGROUND: The exposure of healthcare workers to anticancer drugs such as cyclophosphamide (CPA) is a serious health concern. Anticancer drug pollution may spread outside biological safety cabinets even when a closed system is used. The inhalation of vaporized anticancer drugs is thought to be the primary route of exposure. Therefore, it is important that healthcare workers wear masks to prevent inhalation of anticancer drugs. However, the permeability of medical masks to vaporized anticancer drugs has not been examined. Furthermore, the performance differences between masks including activated carbon with chemical adsorptivity and non-activated carbon masks are uncertain. We investigated activated carbon mask permeability to vaporized CPA, and assessed whether inhibition of vaporized CPA permeability was attributable to the masks’ adsorption abilities. METHODS: A CPA solution (4 mg) was vaporized in a chamber and passed through three types of masks: Pleated-type cotton mask (PCM), pleated-type activated carbon mask (PAM), and stereoscopic-type activated carbon mask (SAM); the flow rate was 1.0 L/min for 1 h. The air was then recovered in 50 % ethanol. CPA quantities in the solution were determined by liquid chromatography time-of-flight mass spectrometry. To determine CPA adsorption by the mask, 5 cm(2) of each mask was immersed in 10 mL of CPA solution (50–2500 μg/mL) for 1 h. CPA concentrations were measured by high-performance liquid chromatography with ultraviolet detection. RESULTS: For the control (no mask), 3.735 ± 0.543 μg of CPA was recovered from the aerated solution. Significantly lower quantities were recovered from PCM (0.538 ± 0.098 μg) and PAM (0.236 ± 0.193 μg) (p < 0.001 and p < 0.001 vs control, respectively). CPA quantities recovered from all of SAM samples were below the quantification limit. When a piece of the SAM was immersed in the CPA solution, a marked decrease to less than 3.1 % of the initial CPA concentration was observed. CONCLUSION: The SAM exhibited good adsorption ability, and this characteristic may contribute to avoiding inhalation exposure to vaporized CPA. These results suggest that wearing activated carbon masks may prevent anticancer drug inhalation by healthcare workers.
format Online
Article
Text
id pubmed-5094061
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50940612016-11-08 Effectiveness of activated carbon masks in preventing anticancer drug inhalation Sato, Junya Kogure, Atushi Kudo, Kenzo J Pharm Health Care Sci Research Article BACKGROUND: The exposure of healthcare workers to anticancer drugs such as cyclophosphamide (CPA) is a serious health concern. Anticancer drug pollution may spread outside biological safety cabinets even when a closed system is used. The inhalation of vaporized anticancer drugs is thought to be the primary route of exposure. Therefore, it is important that healthcare workers wear masks to prevent inhalation of anticancer drugs. However, the permeability of medical masks to vaporized anticancer drugs has not been examined. Furthermore, the performance differences between masks including activated carbon with chemical adsorptivity and non-activated carbon masks are uncertain. We investigated activated carbon mask permeability to vaporized CPA, and assessed whether inhibition of vaporized CPA permeability was attributable to the masks’ adsorption abilities. METHODS: A CPA solution (4 mg) was vaporized in a chamber and passed through three types of masks: Pleated-type cotton mask (PCM), pleated-type activated carbon mask (PAM), and stereoscopic-type activated carbon mask (SAM); the flow rate was 1.0 L/min for 1 h. The air was then recovered in 50 % ethanol. CPA quantities in the solution were determined by liquid chromatography time-of-flight mass spectrometry. To determine CPA adsorption by the mask, 5 cm(2) of each mask was immersed in 10 mL of CPA solution (50–2500 μg/mL) for 1 h. CPA concentrations were measured by high-performance liquid chromatography with ultraviolet detection. RESULTS: For the control (no mask), 3.735 ± 0.543 μg of CPA was recovered from the aerated solution. Significantly lower quantities were recovered from PCM (0.538 ± 0.098 μg) and PAM (0.236 ± 0.193 μg) (p < 0.001 and p < 0.001 vs control, respectively). CPA quantities recovered from all of SAM samples were below the quantification limit. When a piece of the SAM was immersed in the CPA solution, a marked decrease to less than 3.1 % of the initial CPA concentration was observed. CONCLUSION: The SAM exhibited good adsorption ability, and this characteristic may contribute to avoiding inhalation exposure to vaporized CPA. These results suggest that wearing activated carbon masks may prevent anticancer drug inhalation by healthcare workers. BioMed Central 2016-11-03 /pmc/articles/PMC5094061/ /pubmed/27826453 http://dx.doi.org/10.1186/s40780-016-0062-7 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Sato, Junya
Kogure, Atushi
Kudo, Kenzo
Effectiveness of activated carbon masks in preventing anticancer drug inhalation
title Effectiveness of activated carbon masks in preventing anticancer drug inhalation
title_full Effectiveness of activated carbon masks in preventing anticancer drug inhalation
title_fullStr Effectiveness of activated carbon masks in preventing anticancer drug inhalation
title_full_unstemmed Effectiveness of activated carbon masks in preventing anticancer drug inhalation
title_short Effectiveness of activated carbon masks in preventing anticancer drug inhalation
title_sort effectiveness of activated carbon masks in preventing anticancer drug inhalation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094061/
https://www.ncbi.nlm.nih.gov/pubmed/27826453
http://dx.doi.org/10.1186/s40780-016-0062-7
work_keys_str_mv AT satojunya effectivenessofactivatedcarbonmasksinpreventinganticancerdruginhalation
AT kogureatushi effectivenessofactivatedcarbonmasksinpreventinganticancerdruginhalation
AT kudokenzo effectivenessofactivatedcarbonmasksinpreventinganticancerdruginhalation